AI assistant
Sending…
RESMED INC — Director's Dealing 2022
Nov 17, 2022
30071_dirs_2022-11-16_6ebe7bda-f3c5-419a-8581-8580ca3f29e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-11-15
Reporting Person: BLAISE LUCILE (President, Sleep & RC Business)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-15 | ResMed Common Stock | M | 516 | $225.18 | Acquired | 7504 | Direct |
| 2022-11-15 | ResMed Common Stock | S | 169 | $225.18 | Disposed | 7335 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan.
F2: Includes 72.515 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29